Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

Hepatology Research, EarlyView.

Source: Hepatology Research - February 21, 2018 Category: Internal Medicine Source Type: research